Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$105.81
1.981.91%
Last update: Oct 6, 12:06 PM
$103.80
-0.03-0.03%
Insmed Inc (INSM) Stock Price, Quote, News & History
INSMNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products,...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Other companies in Insmed’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Insmed has a consensus price target of $197.15.
The stock price for Insmed (NASDAQ: INSM) is $105.815 last updated October 6, 2026 at 12:06 PM EDT.
There are no upcoming dividends for Insmed.
Insmed does not have any upcoming earnings scheduled.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
